I always wonder when reading Ray Blanco's work....
"As you know, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) recently received FDA approval for its breakthrough hepatitis C drug Incivek. Shortly after the event, I recommended taking some profits while retaining a core position. Some of our...